Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | 1-(3-Chloropropyl)-4-(4-fluorophenyl)piperazine | HCID 10682556 | — |
| Reactant | HCID 14580055 | HCID 14580055 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 14580056 | HCID 14580056 | 44.7% |
Reaction Steps
The experiment is carried out as in Example 18, starting with 6-chloronaphtho[1,8-cd]isothiazole 1,1-dioxide (1.4 g), 1-(3-chloropropyl)-4-(4-fluorophenyl) piperazine (1.5 g), sodium hydride (0.18 g) in an 80dispersion in vaseline oil and dimethylformamide (15 cc). The reaction mixture is heated for 1 hour 30 minutes at 90° C., cooled to a temperature of about 20° C. and then concentrated to dryness at 60° C. under reduced pressure (0.5 mm Hg; 0.07 kPa). The residue is redissolved in dichloromethane (50 cc) and the solution is washed with distilled water (20 cc), dried over magnesium sulphate and concentrated to dryness at 20° C. under reduced pressure (20 mm Hg; 2.7 kPa). The residue is purified by chromatography on a silica column with a mixture of dichloromethane and ethyl acetate (95-5 vol) as eluant, then recrystallized from boiling acetonitrile (10 cc). 6-Chloro-2-{3-[4-(4-fluorophenyl)-1-piperazinyl]propyl}-naphtho[1,8-cd]isothiazole 1,1-dioxide (1.2 g) is obtained, m.p. 125° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US05021420 |
|---|
| Source dataset | uspto-grants-1991_06 |
|---|
| ORD ID | ord-23eaaf79b3274521a64752439a0d3e84 |
|---|
| Source note | uspto-grants-1991_06 |
|---|